{"id":6356,"date":"2022-08-31T11:02:36","date_gmt":"2022-08-31T15:02:36","guid":{"rendered":"https:\/\/aafa.org\/?post_type=asthma_medicine&p=6356"},"modified":"2026-03-23T17:26:13","modified_gmt":"2026-03-23T21:26:13","slug":"dupilumab-dupixent","status":"publish","type":"asthma_medicine","link":"https:\/\/aafa.org\/asthma-medicine\/dupilumab-dupixent\/","title":{"rendered":"Dupilumab – DUPIXENT"},"content":{"rendered":"

[et_pb_section fb_built=”1″ admin_label=”Main Content” _builder_version=”4.17.4″ _module_preset=”default” custom_padding=”2%||2%||true|false” global_colors_info=”{}”][et_pb_row column_structure=”2_3,1_3″ _builder_version=”4.17.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”2_3″ _builder_version=”4.17.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_post_title meta=”off” featured_image=”off” admin_label=”Page Title” module_class=”tert-content q” _builder_version=”4.17.4″ _module_preset=”default” title_font=”|600|||||||” title_text_align=”left” title_text_color=”#008c99″ title_font_size=”39px” background_enable_image=”off” background_size=”contain” background_position=”center_left” module_alignment=”left” custom_margin=”||0px||false|false” custom_padding=”||||false|false” global_colors_info=”{}”][\/et_pb_post_title][et_pb_code admin_label=”Breadcrumbs” module_class=”bcrumb2″ _builder_version=”4.18.0″ _module_preset=”default” text_orientation=”left” custom_margin=”||||false|false” custom_padding=”||||false|false” custom_css_main_element=”font-size:16px;||color: #008c99;” global_module=”1658″ global_colors_info=”{}”][\/et_pb_code][et_pb_text admin_label=”Regular Content” _builder_version=”4.24.2″ _module_preset=”default” text_text_color=”#505050″ global_colors_info=”{}”]<\/p>\n

Drug Name<\/strong>: Dupilumab<\/p>\n

Brand Name: <\/strong>DUPIXENT\u00ae<\/a><\/p>\n

Medicine Use:<\/strong> Add-on therapy\/long-term control<\/p>\n

Type of Medicine<\/strong>: Biologic<\/p>\n

Form<\/strong>: Injection<\/p>\n

Prescribing Info<\/strong>: DUPIXENT (dupilumab) injection prescribing information insert<\/a>\"Download<\/p>\n

Notes:<\/strong><\/p>\n

DUPIXENT is a maintenance treatment for moderate-to-severe asthma caused by type 2 inflammation (which includes eosinophilic asthma and\/or allergic asthma). DUPIXENT is also approved to treat moderate-to-severe atopic dermatitis (eczema), chronic rhinosinusitis with nasal polyposis, eosinophilic esophagitis, and prurigo nodularis.<\/p>\n

Learn more about dupilumab in pregnancy and while breastfeeding.<\/a><\/p>\n

Possible Side Effects:<\/strong>
Joint pain
Injection site reactions (pain, redness, swelling, itching, or a burning feeling at the injection site)
Upper respiratory tract infections
Eye and eyelid inflammation
Dry eye
Herpes virus infections
Common cold symptoms
Cold sores in your mouth or on your lips
Throat pain
High count of a certain white blood cell (eosinophilia)
Dizziness
Muscle pain
Diarrhea
Gastritis
Toothache
Trouble sleeping (insomnia)
Parasitic infections<\/p>\n

[\/et_pb_text][et_pb_text admin_label=”Copay Assistance – Callout Box” _builder_version=”4.27.4″ _module_preset=”default” text_text_color=”#505050″ link_font=”||||on|||#008c99|” link_text_color=”#008c99″ link_line_height=”1.7em” ul_line_height=”1.7em” header_2_font=”|600|||||||” header_2_text_color=”#008c99″ header_2_font_size=”39px” header_3_font=”|600|||||||” header_3_text_align=”left” header_3_text_color=”#008c99″ header_3_font_size=”28px” background_color=”#dbdbdb” custom_padding=”4%|4%|4%|4%|true|true” hover_enabled=”0″ box_shadow_style=”preset2″ global_colors_info=”{}” sticky_enabled=”0″]<\/p>\n

Copay Assistance Programs for DUPIXENT<\/h2>\n

If you have commercial insurance:<\/strong>\u00a0The Dupixent MyWay\u00ae Copay Card may help you lower the cost of your copay. Learn more on the Dupixent MyWay<\/em> Copay Card website<\/a><\/strong> or call 844-DUPIXENT (844-387-4936), option 1.<\/strong><\/p>\n

If you don’t have insurance or your insurance doesn\u2019t cover Dupixent:<\/strong>\u00a0You can apply for the DUPIXENT MyWay Patient Assistance Program<\/a><\/em><\/strong>. For more information or to sign up, call 844-DUPIXENT (844-387-4936), option 1<\/strong>.<\/p>\n

If you have Medicare:<\/strong>\u00a0At this time, there is not a savings program for Dupixent if you have Medicare. Call 844-DUPIXENT (844-387-4936), option 1<\/strong> for more information.<\/p>\n

If you have Medicaid:<\/strong>\u00a0Your copay and coverage may vary depending on what state you live in. If you meet the criteria, you may also be able to get help from the DUPIXENT MyWay Patient Assistance Program<\/a><\/em><\/strong>. For more information or to sign up, call 844-DUPIXENT (844-387-4936), option 1<\/strong>.<\/p>\n

[\/et_pb_text][et_pb_code admin_label=”Print” module_id=”print” module_class=”clearfix” _builder_version=”4.17.6″ _module_preset=”default” global_module=”5156″ saved_tabs=”all” global_colors_info=”{}”]<\/svg> Print post<\/a> [\/et_pb_code][\/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.17.4″ _module_preset=”default” custom_padding=”6%||||false|false” global_colors_info=”{}”][et_pb_image src=”https:\/\/aafa.org\/wp-content\/uploads\/2022\/08\/Dupixent_200mg__300mg_Syringes_v2_HR_archive.png” alt=”Dupixent Injection Syringes” title_text=”Dupixent_200mg__300mg_Syringes_v2_HR_archive” show_in_lightbox=”on” admin_label=”Picture” _builder_version=”4.18.0″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"featured_media":0,"template":"","meta":{"_acf_changed":false,"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","_links_to":"","_links_to_target":""},"medicine_use":[20],"type_of_medicine":[23],"class_list":["post-6356","asthma_medicine","type-asthma_medicine","status-publish","hentry","medicine_use-long-term-control","type_of_medicine-biologics"],"acf":[],"yoast_head":"\nDupilumab - DUPIXENT - Asthma and Allergy Foundation of America<\/title>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\t\n